Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Neuropathological correlates and genetic architecture of microglial activation in elderly human brain

Open access

Published version of a preprint

Abstract

Microglia, the resident immune cells of the brain, have important roles in brain health. However, little is known about the regulation and consequences of microglial activation in the aging human brain. Here we report that the proportion of morphologically activated microglia (PAM) in postmortem cortical tissue is strongly associated with β-amyloid, tau-related neuropathology, and the rate of cognitive decline. Effect sizes for PAM measures are substantial, comparable to that of APOE ε4, the strongest genetic risk factor for Alzheimer’s disease, and mediation models support an upstream role for microglial activation in Alzheimer’s disease via accumulation of tau. Further, we identify a common variant (rs2997325) influencing PAM that also affects in vivo microglial activation measured by [ 11 C]-PBR28 PET in an independent cohort. Thus, our analyses begin to uncover pathways regulating resident neuroinflammation and identify overlaps of PAM’s genetic architecture with those of Alzheimer’s disease and several other traits.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-08279-3

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flowchart of analyses performed in this study. ROS Religious Orders Study, MAP Memory and Aging Project, PAM proportion of activated microglia, AD Alzheimer’s disease, FUMAGWAS functional mapping and annotation of genome-wide association studies, IMAS Indiana Memory and Aging Study, GTEx Genotype and Tissue Expression Study, BRAINEAC Brain eQTL Almanac, CADD combined annotation-dependent depletion, MSigDB the Molecular Signature Database. Beta amyloid figure adapted from Darvesh, Hopkins & Geula (2003) https://www.nature.com/articles/nrn1035#rightslink. Neurofibrillary tangles figure adapted from Alzheimer (1911) Ueber eigenartige Krankheitsfaelle des spaeteren Alters (10.1177/0957154×9100200506)
Fig. 1 Flowchart of analyses performed in this study. ROS Religious Orders Study, MAP Memory and Aging Project, PAM proportion of activated microglia, AD Alzheimer’s disease, FUMAGWAS functional mapping and annotation of genome-wide association studies, IMAS Indiana Memory and Aging Study, GTEx Genotype and Tissue Expression Study, BRAINEAC Brain eQTL Almanac, CADD combined annotation-dependent depletion, MSigDB the Molecular Signature Database. Beta amyloid figure adapted from Darvesh, Hopkins & Geula (2003) https://www.nature.com/articles/nrn1035#rightslink. Neurofibrillary tangles figure adapted from Alzheimer (1911) Ueber eigenartige Krankheitsfaelle des spaeteren Alters (10.1177/0957154×9100200506)CC BY · PubMed Central
Fig. 2 Regional distributions of microglial density phenotypes between pathological AD and non-AD. a Representative immunohistochemistry images of microglial staging in the MAP cohort. Scale bars are 10 µm. b Density plots showing the distributions of all stages of microglia (total count), active microglia (stage III only), and PAM across four brain regions (nMF = 225, nIT = 219, nPPUT = 198, nVM = 218). P-values are two-sided for Welch t-tests of means between AD and non-AD. c Receiver operating characteristic (ROC) curves showing model performance for cortical PAM phenotypes in logistic regression, with pathological AD diagnosis as outcome, and co-variates as specified. Area under the curve (AUC) values are for non-bootstrapped models. IT inferior temporal cortex, MF midfrontal cortex, PPUT posterior putamen, VM ventral medial caudate
Fig. 2 Regional distributions of microglial density phenotypes between pathological AD and non-AD. a Representative immunohistochemistry images of microglial staging in the MAP cohort. Scale bars are 10 µm. b Density plots showing the distributions of all stages of microglia (total count), active microglia (stage III only), and PAM across four brain regions (nMF = 225, nIT = 219, nPPUT = 198, nVM = 218). P-values are two-sided for Welch t-tests of means between AD and non-AD. c Receiver operating characteristic (ROC) curves showing model performance for cortical PAM phenotypes in logistic regression, with pathological AD diagnosis as outcome, and co-variates as specified. Area under the curve (AUC) values are for non-bootstrapped models. IT inferior temporal cortex, MF midfrontal cortex, PPUT posterior putamen, VM ventral medial caudateCC BY · PubMed Central
Fig. 3 Associations of PAM phenotypes with neuropathology and cognitive decline. a −Log10(p-values), weighted by direction of effect, indicating the strength of evidence for association of each brain-wide neuropathology measure with PAM. b –Log10(p-values), weighted by direction of effect, indicating the strength of evidence for association of each measure of longitudinal cognitive decline with PAM. The red dotted lines in panel a indicate corrected statistical significance thresholds, and the blue dotted lines in both panels indicate uncorrected thresholds of p = 0.05. All p-values are two-sided and calculated from parameter estimates of iterative re-weighted least-squares regression. Model covariates included age at death, postmortem interval, APOE ε4 status, and top three EIGENSTRAT principal components (nMF = 225, nIT = 219, nPPUT = 198, nVM = 218)
Fig. 3 Associations of PAM phenotypes with neuropathology and cognitive decline. a −Log10(p-values), weighted by direction of effect, indicating the strength of evidence for association of each brain-wide neuropathology measure with PAM. b –Log10(p-values), weighted by direction of effect, indicating the strength of evidence for association of each measure of longitudinal cognitive decline with PAM. The red dotted lines in panel a indicate corrected statistical significance thresholds, and the blue dotted lines in both panels indicate uncorrected thresholds of p = 0.05. All p-values are two-sided and calculated from parameter estimates of iterative re-weighted least-squares regression. Model covariates included age at death, postmortem interval, APOE ε4 status, and top three EIGENSTRAT principal components (nMF = 225, nIT = 219, nPPUT = 198, nVM = 218)CC BY · PubMed Central
Fig. 4 Genome-wide association studies (GWAS) of PAM with TSPO PET imaging follow-up. a Manhattan plot, (b) Q–Q plot, and (c) locus summary chart for inferior temporal cortex (IT) PAM, and corresponding, (d) Manhattan plot, (e) Q–Q plot, and (f) locus summary chart for midfrontal cortex (MF) PAM GWAS. Both analyses co-varied for genotype platform, age at death, sex, postmortem interval, APOE ε4 status, and top three EIGENSTRAT principal components. g Regional association plot highlighting the MF PAM genome-wide significant locus surrounding rs2997325 (p = 1.88 × 10−8, n = 225). The color of each dot represents degree of linkage disequilibrium at that SNP based on 1000 Genomes Phase 3 reference data. The combined annotation-dependent depletion (CADD) score is plotted below the regional association plot on a scale from 0 to 20, where 20 indicates a variant with highest predicted deleteriousness. The RegulomeDB score is plotted below the CADD score, and summarizes evidence for effects on regulatory elements of each plotted SNP (5 = transcription factor-binding site or DNAase peak, 6 = other motif altered, 7 = no evidence). Below the RegulomeDB plot is an eQTL plot showing –log10(p-values) for association of each plotted SNP with the expression of the mapped gene RP11-170N11.1 (LINC01361). h Strip chart showing the significant relationship between MF PAM (on y-axis as GWAS covariate-only model residuals) and rs2997325 genotype. i Whisker plot showing the means and standard deviations of [11C]-PBR28 standard uptake value ratio (SUVR) for the left entorhinal cortex in the PET imaging sample from the Indiana Memory and Aging Study (p = 0.02, r2 = 17.1, n = 27), stratified by rs2997325 genotype. Model co-varied for TSPO rs6971 genotype, APOE ε4 status, age at study entry, and sex. Tissue enrichment analyses for (j) IT and (k) MF PAM gene sets in 30 general tissue types from GTEx v7 show Bonferroni significant enrichment (two-sided) of only the MF gene set with colon, salivary gland, breast, small intestine, stomach, lung, and blood vessel tissues. Heat maps showing enrichment for all 53 tissue types in GTEx v7, including uni-directional analyses for up-regulation and down-regulation specifically can be found in Supplementary Figure 5
Fig. 4 Genome-wide association studies (GWAS) of PAM with TSPO PET imaging follow-up. a Manhattan plot, (b) Q–Q plot, and (c) locus summary chart for inferior temporal cortex (IT) PAM, and corresponding, (d) Manhattan plot, (e) Q–Q plot, and (f) locus summary chart for midfrontal cortex (MF) PAM GWAS. Both analyses co-varied for genotype platform, age at death, sex, postmortem interval, APOE ε4 status, and top three EIGENSTRAT principal components. g Regional association plot highlighting the MF PAM genome-wide significant locus surrounding rs2997325 (p = 1.88 × 10−8, n = 225). The color of each dot represents degree of linkage disequilibrium at that SNP based on 1000 Genomes Phase 3 reference data. The combined annotation-dependent depletion (CADD) score is plotted below the regional association plot on a scale from 0 to 20, where 20 indicates a variant with highest predicted deleteriousness. The RegulomeDB score is plotted below the CADD score, and summarizes evidence for effects on regulatory elements of each plotted SNP (5 = transcription factor-binding site or DNAase peak, 6 = other motif altered, 7 = no evidence). Below the RegulomeDB plot is an eQTL plot showing –log10(p-values) for association of each plotted SNP with the expression of the mapped gene RP11-170N11.1 (LINC01361). h Strip chart showing the significant relationship between MF PAM (on y-axis as GWAS covariate-only model residuals) and rs2997325 genotype. i Whisker plot showing the means and standard deviations of [11C]-PBR28 standard uptake value ratio (SUVR) for the left entorhinal cortex in the PET imaging sample from the Indiana Memory and Aging Study (p = 0.02, r2 = 17.1, n = 27), stratified by rs2997325 genotype. Model co-varied for TSPO rs6971 genotype, APOE ε4 status, age at study entry, and sex. Tissue enrichment analyses for (j) IT and (k) MF PAM gene sets in 30 general tissue types from GTEx v7 show Bonferroni significant enrichment (two-sided) of only the MF gene set with colon, salivary gland, breast, small intestine, stomach, lung, and blood vessel tissues. Heat maps showing enrichment for all 53 tissue types in GTEx v7, including uni-directional analyses for up-regulation and down-regulation specifically can be found in Supplementary Figure 5CC BY · PubMed Central
Fig. 5 Results of polygenic scoring analysis of PAM GWAS and 29 published traits. a Stratified violin plots for PAM → published trait polygenic analyses, showing –log10(p-values) for genetic score (GRS) associations of inferior temporal cortex (IT) PAM and midfrontal cortex (MF) PAM across all p-value thresholds ranging from 0 to 0.5, with 5.0 × 10−5 regular increments (10,000 total scores). Each PAM genetic score was mapped onto the summary statistics of each published GWAS trait and tested for significance. The dotted line represents a corrected statistical significance threshold of p = 8.6 × 10−4, corrected for 29 GWAS traits and two PAM measures. The width of each violin represents the density of PAM polygenic scores associated with each trait at a given significance. For example, a bottom-skewed violin (e.g. educational attainment (Edu)) indicates that a majority of scores across the tested set of thresholds tended to achieve greater significance, whereas a top-skewed violin (e.g. bipolar disorder (BPD)) indicates that a majority of tested scores tended toward lower significance. Peaks achieving at least one score above corrected statistical significance are labeled for their respective GWAS trait. b Network plot illustrating significant results for PAM → GWAS trait analyses, where an arrow indicates a directional effect of a peak PAM GRS on a GWAS trait at corrected significance (edges are labeled with % variance explained in GWAS trait by optimal PAM GRS, and edge thickness is proportional to the –log(p-value) of the association). c Stratified violin plots for the GWAS trait → PAM analyses, such that GRS were first calculated across thresholds for published traits and then tested against the PAM summary statistics. d Network plot illustrating significant results of the GWAS trait → PAM analyses. GRS genetic risk score, AD Alzheimer’s disease, Edu educational attainment, IBDCD irritable bowel disease, Crohn’s disease; IBDUC irritable bowel disease, ulcerative colitis, CAD coronary artery disease, HIPP hippocampal volume (from MRI), RA rheumatoid arthritis, BPD bipolar disorder, MDD major depressive disorder, HOMA homeostasis model assessment (from fasting insulin and glucose); AtopDerm atopic dermatitis, APOB circulating apolipoprotein B, HDL high-density lipoprotein cholesterol, BMDneck bone marrow density of the neck, SCZ schizophrenia, ADHD attention deficit/hyperactivity disorder. The full list of abbreviations found in the legend and descriptions of each published GWAS, including sample sizes, are listed in Supplementary Data 7
Fig. 5 Results of polygenic scoring analysis of PAM GWAS and 29 published traits. a Stratified violin plots for PAM → published trait polygenic analyses, showing –log10(p-values) for genetic score (GRS) associations of inferior temporal cortex (IT) PAM and midfrontal cortex (MF) PAM across all p-value thresholds ranging from 0 to 0.5, with 5.0 × 10−5 regular increments (10,000 total scores). Each PAM genetic score was mapped onto the summary statistics of each published GWAS trait and tested for significance. The dotted line represents a corrected statistical significance threshold of p = 8.6 × 10−4, corrected for 29 GWAS traits and two PAM measures. The width of each violin represents the density of PAM polygenic scores associated with each trait at a given significance. For example, a bottom-skewed violin (e.g. educational attainment (Edu)) indicates that a majority of scores across the tested set of thresholds tended to achieve greater significance, whereas a top-skewed violin (e.g. bipolar disorder (BPD)) indicates that a majority of tested scores tended toward lower significance. Peaks achieving at least one score above corrected statistical significance are labeled for their respective GWAS trait. b Network plot illustrating significant results for PAM → GWAS trait analyses, where an arrow indicates a directional effect of a peak PAM GRS on a GWAS trait at corrected significance (edges are labeled with % variance explained in GWAS trait by optimal PAM GRS, and edge thickness is proportional to the –log(p-value) of the association). c Stratified violin plots for the GWAS trait → PAM analyses, such that GRS were first calculated across thresholds for published traits and then tested against the PAM summary statistics. d Network plot illustrating significant results of the GWAS trait → PAM analyses. GRS genetic risk score, AD Alzheimer’s disease, Edu educational attainment, IBDCD irritable bowel disease, Crohn’s disease; IBDUC irritable bowel disease, ulcerative colitis, CAD coronary artery disease, HIPP hippocampal volume (from MRI), RA rheumatoid arthritis, BPD bipolar disorder, MDD major depressive disorder, HOMA homeostasis model assessment (from fasting insulin and glucose); AtopDerm atopic dermatitis, APOB circulating apolipoprotein B, HDL high-density lipoprotein cholesterol, BMDneck bone marrow density of the neck, SCZ schizophrenia, ADHD attention deficit/hyperactivity disorder. The full list of abbreviations found in the legend and descriptions of each published GWAS, including sample sizes, are listed in Supplementary Data 7CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 170

Metadata

Authors
Felsky, D., Roostaei, T., Nho, K., Risacher, S. L., Bradshaw, E. M., Petyuk, V., Schneider, J. A., Saykin, A., Bennett, D. A., & De Jager, P. L.
Affiliations
  • Broad Institute (US)
  • Columbia University Irving Medical Center (US)
  • Indiana University School of Medicine (US)
  • Rush University Medical Center (US)
Venue
Nature Communications
Published
2019-01-24
Volume
10
Issue
1
Pages
409-409
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2949280410
Cited by
169
References
48
Citations by year
2026: 9 · 2025: 16 · 2024: 33 · 2023: 18 · 2022: 26 · 2021: 32 · 2020: 25 · 2019: 10
FWCI
10.24
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • IUScholarWorks (Indiana University) (submittedVersion, cc-by-nc-nd)
Funders
  • Illinois Department of Public Health (P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01NS084965)
  • Translational Genomics Research Institute
  • National Institutes of Health
  • Canadian Institutes of Health Research (R01AG17917, R01AG15819, P30AG10161)
  • National Institute on Aging (R01AG017917, R01AG030146, R01AG048015, U01AG046152, R01AG015819, P30AG010161, R03AG054936)
  • National Institute of Neurological Disorders and Stroke (R01NS084965, R01NS089674)
  • U.S. National Library of Medicine (R00LM011384, R01LM012535)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
microglial activation, Alzheimer's disease, amyloid-beta, tau pathology, cognitive decline, APOE ε4, genetic architecture, neuroinflammation, mediation analysis
MeSH terms
Neuropathology, Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Brain, Female, Genotype, Humans, Inflammation, Male, Nervous System Diseases, Phenotype, Risk Factors, Cohort Studies, Logistic Models, Amyloid beta-Peptides, Microglia, Proteomics, Apolipoprotein E4, Genome-Wide Association Study, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. https://app.cochat.ai/papers/10.1038/s41467-018-08279-3
The paper
Felsky, D., Roostaei, T., Nho, K., Risacher, S. L., Bradshaw, E. M., Petyuk, V., Schneider, J. A., Saykin, A., Bennett, D. A., & De Jager, P. L. (2019). Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nature Communications. https://doi.org/10.1038/s41467-018-08279-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.